United States · Funded startup

Who invested in MetaVia

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 10 months ago

Funding summaryUpdated 26 Oct 2026

$9.3Mraised across 1 round since 2026, from 1 source

Latest round
Round, $9.3MJan 2026
Investors
1
See who backed them

The rounds

  1. Jan 2026
    Round$9.3M

    Source recorded

Founders and team

From MetaVia's own website: 7 on the team.

  • Hyung Heon KimChief Executive Officer and President
  • Robert HomolkaSenior Vice President of Clinical Operations
  • Marshall H. WoodworthChief Financial Officer
  • Mi-Kyung KimChief Scientific Officer
  • Andrew KovenChairman of the Board
  • D. Gordon StricklandIndependent Director
  • James P. TursiIndependent Director

AdvisersMichael C. Pine

Everyone who backed them

SVB CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about MetaVia

Who invested in MetaVia?

MetaVia's investors include SVB Capital.

How much has MetaVia raised?

MetaVia has raised $9.3M across 1 round since 2026.

When did MetaVia last raise?

MetaVia's most recent round was an Undisclosed round of $9.3M in Jan 2026.

What was MetaVia's biggest round?

Its most recent round, $9.3M in Jan 2026, is also its largest on record.

Who backed MetaVia first?

MetaVia's first round on record, in Jan 2026, was backed by SVB Capital.

What stage is MetaVia at?

MetaVia's latest named round is an Undisclosed round, in Jan 2026.

Where is MetaVia based?

MetaVia is based in the United States.

Companies like MetaVia

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.